Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Exploring the Mechanism of Chromatin Spatial Structure Changes and Transcriptional Regulation in Age-Related Clonal Hematopoiesis Caused By DNMT3A Mutations Using Chromatin Capture Technology

Yujun Dai, Xue-Ping Li, Yang Liang

Blood (2024) 144 (Supplement 1): 192.

https://doi.org/10.1182/blood-2024-200714

Published: 2024

Journal Articles

Lactate Metabolism-Related Genes to Predict the Clinical Outcome and Molecular Characteristics of Multiple Myeloma

Lingling Shu, Ziang Zhu, Yang Li, Hanying Huang, Xiaoqin Chen, Zhongjun Xia, Yang Liang

Blood (2024) 144 (Supplement 1): 4693.

https://doi.org/10.1182/blood-2024-207432

Published: 2024

Journal Articles

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients with Newly Diagnosed Multiple Myeloma (NDMM): Insights from a Multi-Center Study

Dong Liang, Demei Feng, Qiaoli Wang, Shenrui Bai, Min Zeng, Bo Lu, Xiaoqing Li, Zhiqiang Sun, Jianyun Li, Huanhuan Zhou, Jialu Zhang, Xiaoqin Chen, Zhongjun Xia, Yang Liang, Hua Wang

Blood (2024) 144 (Supplement 1): 7064.

https://doi.org/10.1182/blood-2024-204519

Published: 2024

Journal Articles

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Xiaoqin Chen, Yun Wang, Weida Wang, Hua Wang, Bingyi Wu, Yang Liang, Zhongjun Xia

Blood (2024) 144 (Supplement 1): 7025.

https://doi.org/10.1182/blood-2024-204564

Published: 2024

Journal Articles

Efficacy and Safety of Carfilzomib-Based Regimens in a Real-World Clinical Practice: Insights from China

Dong Liang, Demei Feng, Yang Liang, Hua Wang

Blood (2024) 144 (Supplement 1): 7875.

https://doi.org/10.1182/blood-2024-203304

Published: 2024

Journal Articles

A Retrospective Analysis of Orelabrutinib-Containing Regimen for Marginal Zone Lymphoma

Hua Wang, Yang Liang, Dong Liang, Demei Feng

Blood (2024) 144 (Supplement 1): 6332.

https://doi.org/10.1182/blood-2024-203319

Published: 2024

Journal Articles

Haploidentical Transplant Using Selective Ex-vivo TCR-Αβ Depleted and Upfront Memory T-Cell Add-Back Is Associated with Lower Chronic Gvhd and More Favorable Gvhd-Free/Relapse-Free Survival As Compared to Matched Related and Unrelated Donor Transplant for Adults with Hematological Malignancies

Blood (2024) 144 (Supplement 1): 3529.

https://doi.org/10.1182/blood-2024-200952

Published: 2024

Journal Articles

Efficiency and Safety of Pegylated Filgrastim Combined with Plerixafor in Multiple Myeloma Autologous Hematopoietic Stem Cells Mobilization

Chenfei Liu, Yuanbin Song, Yang Liang, Lu Lu, Weida Wang, Bingyi Wu

Blood (2024) 144 (Supplement 1): 7118.

https://doi.org/10.1182/blood-2024-207526

Published: 2024

Journal Articles

Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia

Yang Liang, Yuanbin Song, Chenfei Liu, Lu Lu, Bingyi Wu, Weida Wang, Shuzhao Chen, Lezong Chen

Blood (2024) 144 (Supplement 1): 6713.

https://doi.org/10.1182/blood-2024-207749

Published: 2024

Journal Articles

Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)

Huafeng Wang, Xudong Wei, Yang Liang, Jianyu Weng, Wenjuan He, Chunkang Chang, Suning Chen, Hongbing Ma, Zi Chen, Lichuang Men, Lihui Liu, Xiaohong Tian, Zhang Zhang, Danhua Cong, Dajun Yang, Yifan Zhai, Jie Jin

Blood (2024) 144 (Supplement 1): 3202.

https://doi.org/10.1182/blood-2024-205371

Published: 2024

Journal Articles

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

Yun Wang, Weida Wang, Jingbo Xu, Ji Ma, Hua Wang, Bingyi Wu, Yuanbin Song, Weiran Lv, Lezong Chen, Jun Ma, Tiejun Gong, Yang Liang

Blood (2024) 144 (Supplement 1): 6074.

https://doi.org/10.1182/blood-2024-209055

Published: 2024

Journal Articles

A Prognostic Nomogram Survival Model for Newly Diagnosed Patients with AIDS-Related Diffuse Large B-Cell Lymphoma: A Multicenter Cohort Study in China

Tao Yang, Yang Liang, Chaoyu Wang, Jun Liu, Yan Wu, Haiyan Min, Yunhong Huang, Guo Wei, Wei Zhang, Min Wang, Xiaoqiong Tang, Zailin Yang, Li Jun, Hui Zhou, Yao Liu

Blood (2023) 142 (Supplement 1): 4480.

https://doi.org/10.1182/blood-2023-179132

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine, Low Dose Cytarabine, Aclarubicin and G-CSF (VA-CAG Regimen) for Newly Diagnosed Young Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase 2 Clinical Trial

Xiaoping Li, Xiaoyan Li, Yanling Jin, Zucong Chen, Yonglin Shen, Zhongtao Yuan, Lin Liu, Yu Li, Le Luo, Shiqian Hou, Chaoyang Zhou, Chie Qiu, Kui Zhang, Chunfu Li, Yang Liang, Sanbin Wang, Sr.

Blood (2023) 142 (Supplement 1): 834.

https://doi.org/10.1182/blood-2023-174469

Published: 2023

Journal Articles

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

Blood (2023) 142 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2023-188196

Published: 2023

Journal Articles

AK117 (anti-CD47 monoclonal antibody) in Combination with Azacitidine for Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS): AK117-103 Phase 1b Results

Miao Miao, Qingliang Teng, Depei Wu, Zhongxing Jiang, Songfu Jiang, Fei Li, Yang Liang, Zhongmin Maxwell Wang, Baiyong Li, Yu Xia, Hongyan Tong

Blood (2023) 142 (Supplement 1): 1865.

https://doi.org/10.1182/blood-2023-179099

Published: 2023

Journal Articles

FLT3-ITD Induces Immune Escape in AML Via up-Regulating CD47 Expression and Decreased Phagocytic Ability of Macrophages

Yun Wang, Shuzhao Chen, Limei Zhang, Jiangtao Song, Huaze Liao, Mayan Huang, Kunying Xie, Robert Peter Gale, Yang Liang

Blood (2023) 142 (Supplement 1): 2962.

https://doi.org/10.1182/blood-2023-190969

Published: 2023

Journal Articles

Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

Blood (2023) 142 (Supplement 1): 869.

https://doi.org/10.1182/blood-2023-187740

Published: 2023

Journal Articles

Single Cell Analyses Indicate SRSF2 and TET2 Co-Mutation Results in Skewed Haematopoiesis in Myelodysplastic Syndromes

Fang Hu, Xiaojin Li, Robert Peter Gale, Suning Chen, Yang Liang

Blood (2023) 142 (Supplement 1): 1848.

https://doi.org/10.1182/blood-2023-184508

Published: 2023

Journal Articles

Potential Significance of CTPS1 in Multiple Myeloma

Han-Ying Huang, Yang Liang

Blood (2023) 142 (Supplement 1): 6578.

https://doi.org/10.1182/blood-2023-184540

Published: 2023

Journal Articles

Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China

Kaiyang Ding, Yue-Xin Cheng, Xiaoyong Wang, Chen Huang, Yang Liang, Wei Li, Jingjing Ye, Chunyan Ji

Blood (2023) 142 (Supplement 1): 6552.

https://doi.org/10.1182/blood-2023-189115

Published: 2023

NARROW

Exploring the Mechanism of Chromatin Spatial Structure Changes and Transcriptional Regulation in Age-Related Clonal Hematopoiesis Caused By DNMT3A Mutations Using Chromatin Capture Technology

Lactate Metabolism-Related Genes to Predict the Clinical Outcome and Molecular Characteristics of Multiple Myeloma

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients with Newly Diagnosed Multiple Myeloma (NDMM): Insights from a Multi-Center Study

Safety and Efficacy of Selinexor Plus Bortezomib, Lenalidomide and Dexamethasone (XVRd) in High Risk Newly Diagnosed Multiple Myeloma: A Multi-Center, Single-Arm, Phase Ib/II Trial

Efficacy and Safety of Carfilzomib-Based Regimens in a Real-World Clinical Practice: Insights from China

A Retrospective Analysis of Orelabrutinib-Containing Regimen for Marginal Zone Lymphoma

Haploidentical Transplant Using Selective Ex-vivo TCR-Αβ Depleted and Upfront Memory T-Cell Add-Back Is Associated with Lower Chronic Gvhd and More Favorable Gvhd-Free/Relapse-Free Survival As Compared to Matched Related and Unrelated Donor Transplant for Adults with Hematological Malignancies

Efficiency and Safety of Pegylated Filgrastim Combined with Plerixafor in Multiple Myeloma Autologous Hematopoietic Stem Cells Mobilization

Safety and Efficacy of Luspatercept in Low-Risk Myelodysplastic Neoplasms with Anaemia

Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)

Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia

A Prognostic Nomogram Survival Model for Newly Diagnosed Patients with AIDS-Related Diffuse Large B-Cell Lymphoma: A Multicenter Cohort Study in China

Venetoclax Plus Azacitidine, Low Dose Cytarabine, Aclarubicin and G-CSF (VA-CAG Regimen) for Newly Diagnosed Young Patients with Acute Myeloid Leukemia: A Prospective, Multicenter, Single-Arm Phase 2 Clinical Trial

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

AK117 (anti-CD47 monoclonal antibody) in Combination with Azacitidine for Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS): AK117-103 Phase 1b Results

FLT3-ITD Induces Immune Escape in AML Via up-Regulating CD47 Expression and Decreased Phagocytic Ability of Macrophages

Olverembatinib (HQP1351) Demonstrates Efficacy Vs. Best Available Therapy (BAT) in Patients (Pts) with Tyrosine Kinase Inhibitor (TKI)-Resistant Chronic Myeloid Leukemia Chronic-Phase (CML-CP) in a Registrational Randomized Phase 2 Study

Single Cell Analyses Indicate SRSF2 and TET2 Co-Mutation Results in Skewed Haematopoiesis in Myelodysplastic Syndromes

Potential Significance of CTPS1 in Multiple Myeloma

Effectivness and Safety of Orelabrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective, Real-World Study in China

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only